Company: OPGN
Filing Date: 2025-08-21
Form Type: 10-K
Source: 0001829126-25-006628
Chunk: 745

Company: OPGEN INC
Filing Date: 2025-08-21
Form: 10-K
Item: Item 3
Chunk 745
---
070,779

    $
    100,708

    250

    $
    2

    $
    300,780,440

    $
    -

    $
    (293,500,522
    )
     
    $
    7,380,628

See accompanying notes to consolidated financial statements.

F-7

OpGen, Inc.

Consolidated Statements of Cash Flows

    Year Ended December 31,

    2024

    2023

    Cash flows from operating activities:

    Net income (loss)
     
    $
    11,992,780

    $
    (32,668,530
    )
  
    Adjustments to reconcile net income (loss) to net cash used in operating activities:

    Depreciation and amortization

    174,773

    1,318,597

    Noncash interest expense

    -

    1,741,422

    Change in inventory reserve

    (54,830
    )

    797,840

    Stock compensation expense

    602,433

    235,974

    Loss on sale of equipment

    -

    10,288

    Cash bonus taken in the form of stock compensation

    -

    283,554

    Loss on deconsolidation of subsidiaries

    75,138

    12,979,061

    Change in fair value of derivative financial instruments

    -

    (64,259
    )
  
    Change in fair value of EIB loan guaranty

    (10,873,867
    )

    -

    Gain on impairment adjustment

    (2,079,575
    )

    -

    Gain on settlement of compensation expense

    (570,785
    )

    -

    Impairment of right-of-use asset

    -

    849,243

    Impairment of property and equipment

    -

    1,231,874

    Changes in operating assets and liabilities:

    Accounts receivable

    74,058

    39,115

    Inventory

    54,830

    748,445

    Other assets

    (4,657,565
    )

    (259,173
    )
  
    Accounts payable

    134,047

    (24,158
    )
  
    Accrued compensation and other liabilities

    284,745

    (1,